Texas Children's Hospital, Baylor College of Medicine
Welcome,         Profile    Billing    Logout  
 9 Trials 
13 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Carter, Beth A
TRIUMPH, NCT04862221: TReatment for ImmUne Mediated PathopHysiology

Recruiting
2
163
US
High-dose methylprednisolone, Solu-Medrol, Equine anti-thymocyte globulin, ATGAM, Prednisolone, 15 mg/mL oral solution National Drug Code: 62135-250-37, Placebo for prednisolone, Placebo for infusions, 0.9% Sodium chloride, Diphenhydramine, Benadryl, Methylprednisolone
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Ann & Robert H Lurie Children's Hospital of Chicago
Acute Liver Failure, Fulminant Hepatic Failure, Hepatic Encephalopathy, Acute Liver Injury, Immune Dysregulation
01/26
01/27
Muscal, Jodi
CAMPFIRE, NCT05999994: A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer

Recruiting
2
105
Europe, Japan, US, RoW
Ramucirumab, LY3009806, Cyclophosphamide, Vinorelbine, Gemcitabine, LY188011, Docetaxel, Abemaciclib, LY2835219, Irinotecan, Temozolomide
Eli Lilly and Company
Neoplasms, Child, Adolescent
05/27
05/27
NCT03654716: Phase 1 Study of the Dual MDM2/MDMX Inhibitor ALRN-6924 in Pediatric Cancer

Completed
1
21
US
ALRN-6924, Cytarabine, Cytosar
Dana-Farber Cancer Institute, TeamConnor Childhood Cancer Foundation, Cookies for Kids' Cancer, Aileron Therapeutics, Inc.
Leukemia, Brain Tumor, Solid Tumor, Lymphoma
07/23
07/23
Ruiz, Fadel
STAR-TER, NCT03489629: STaph Aureus Resistance-Treat Early and Repeat

Recruiting
2
42
US
Trimethoprim Sulfamethoxazole (TMP/SMX), Septra, Bactrim, Minocycline, Cleeravue-M, Dynacin, Minocin, Solodyn, Vectrin, Mupirocin, Bactroban, Centany, Chlorhexidine Gluconate, Dyna-Hex, Environmental Decontamination, Sani-Cloth wipes
University of North Carolina, Chapel Hill, University of Washington, Cook Children's Medical Center, Indiana University, University of Michigan, University of Texas Southwestern Medical Center, St. Louis Children's Hospital
Cystic Fibrosis
08/25
12/25
STOP PEDS RCT, NCT06654752: Streamlined Treatment of Pulmonary Exacerbations in Pediatrics

Recruiting
N/A
430
Canada, US
Immediate Oral Antibiotics, Tailored Treatment: Oral Antibiotics only if Additional Treatment needed
University of Washington, the Collaborative Health Studies Coordinating Center, Cystic Fibrosis Foundation
Cystic Fibrosis
12/27
02/29
McMullen-Jackson, Chivon D
NCT02140255: Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission

Recruiting
1/2
1120
US, RoW
Nucleoside Reverse Transcriptase Inhibitors (NRTIs), Nevirapine (NVP), Lopinavir/Ritonavir (LPV/r), Raltegravir (RAL), VRC01, DTG, VRC07-523LS
National Institute of Allergy and Infectious Diseases (NIAID), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institute of Mental Health (NIMH)
HIV Infection
01/28
12/31
NCT05406583: A Study of the Safety, Tolerability, and Pharmacokinetics of Dolutegravir in Neonates Exposed to HIV-1

Recruiting
1
36
US, RoW
Dolutegravir 0.5 mg/kg oral suspension, DTG, Dolutegravir 5 mg Dispersible Tablets
National Institute of Allergy and Infectious Diseases (NIAID), ViiV Healthcare, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institute of Mental Health (NIMH)
HIV
09/25
11/25
NCT04518228: Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and Postpartum

Recruiting
N/A
325
US, RoW
Bictegravir (BIC), Tenofovir alafenamide (TAF), Cabotegravir (CAB), Dolutegravir (DTG), Atazanavir/ritonavir (ATV/r), Darunavir/ritonavir (DRV/r), Lopinavir/ritonavir (LPV/r), Cobicistat, Ritonavir, First-Line TB Treatment, Second-Line TB Treatment, Doravirine (DOR)
National Institute of Allergy and Infectious Diseases (NIAID), International Maternal Pediatric Adolescent AIDS Clinical Trials Group, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institute of Mental Health (NIMH), Gilead Sciences, ViiV Healthcare, Merck Sharp & Dohme LLC
HIV Infections, Tuberculosis
03/26
03/26
Satter, Lisa Forbes
NCT05438407 / 2022-001624-14: Pediatric Patients Aged 4 to 11 Years with APDS

Active, not recruiting
3
15
Europe, Japan, US
Leniolisib
Pharming Technologies B.V., CMIC Co, Ltd. Japan, Labcorp Central Laboratory, Fortrea, Aixial Group
APDS
07/25
12/25
NCT05693129: Pediatric Patients Aged 1 to 6 Years with APDS

Recruiting
3
15
Europe, Japan, US
Leniolisib
Pharming Technologies B.V., CMIC Co, Ltd. Japan, Labcorp Central Laboratory, Fortrea, Aixial Group
APDS
09/25
02/26
NCT03906318: Expanded Access Use of Itacitinib to Treat a Single Patient With Aplastic Anemia

No Longer Available
N/A
NA
Iticitinib
Incyte Corporation
Aplastic Anemia
 
 
NCT05561985: Expanded Access Use of Itacitinib to Treat a Single Patient With STAT1 Gain of Function (GOF) Disease

Available
N/A
NA
Itacitinib, INCB039110
Incyte Corporation
STAT1 Gain-of-Function Disease
 
 
Aina, Titilopemi
iFAD, NCT02591745: International Fetal Anesthesia Database

Active, not recruiting
N/A
2000
US
Fetal intervention
Baylor College of Medicine, Children's Hospital Medical Center, Cincinnati, Universitaire Ziekenhuizen KU Leuven, The University of Texas Health Science Center, Houston
Determination of Neurological Outcomes
01/27
01/30

Download Options